The jointly organized by China Pharmaceutical Business Association and Sinopharm Global Procurement and Supply Chain Service Center was held in Shanghai recently. Mr. Kevin Gu, Senior Vice President, Head of Market Access, Commercial Diversity & International Business of Hasten Biopharmaceutical Co., Ltd. was invited to attend the conference and delivered a speech on "Exploring Supply Chain Integration Development for Innovative Pharmaceutical Enterprises".

Founded in 2020, Hasten is focused on addressing unmet needs in the chronic disease and critical care areas. In order to quickly improve the supply system and expand the process benefits in a short period of time, Hasten, with its strong commercialization capability, promotes leverage effect for different products, leverages diverse resources to connect the upstream and downstream industry chains, while initiates a new cooperation with light operation mode in offline retailers as well as online e-commerce platforms and internet hospitals, promoting medical digital marketing innovation model to create a closed loop of medical services.

“With the great support from strategic partners such as Sinopharm Group, Hasten gains rapid development in the past year.” Said by Kevin Gu during his speech on the conference, “As a young biopharmaceutical company, facing the differentiated supply chain system of different products and diversified supply demands, it is very challenging to develop a broad and precise business coverage in a short period of time. In the face of challenges, Relying on the strong e-commerce services and retail network of Sinopharm Jiangsu and Jointown Pharmaceutical Group, Hasten quickly establishes an innovative cooperation model for supply and logistics management, which helps to enhance patients’ and clinical benefits while realizing commercial returns. We would like to continue to joint hands with industry partners to serve patients with digitalized and innovative forms, and build a health management ecosystem together.”